T1	Participants 35 60	malaria chemoprophylaxis:
T2	Participants 161 277	users of malaria chemoprophylaxis regimens (atovaquone-proguanil, chloroquine-proguanil, doxycycline, or mefloquine)
T3	Participants 283 332	group of nonimmune tourists to sub-Saharan Africa
T4	Participants 445 478	Switzerland, Germany, and Israel,
T5	Participants 1461 1476	median age 34 y